• Cellumed's Nov. 12, 2026, correction finalized a capital reduction proposal for the Nov. 27 extraordinary shareholders' meeting.
• Shareholders will also vote on financial statements, director appointments and amendments to the articles of incorporation.
• The meeting will revisit business left unresolved when the March 31, 2026, annual shareholders' meeting failed to reach a quorum.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellumed Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261112901193), on November 12, 2026, and is solely responsible for the information contained therein.